The "switch process" in manic-depressive illness. 3. Theoretical implications.
D001693:Biological Transport, Active; D001714:Bipolar Disorder / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002254:Carbonates / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D006801:Humans; D008094:Lithium / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D008274:Magnesium / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011955:Receptors, Drug; D012964:Sodium / Q000378:metabolism; D019966:Substance-Related Disorders; D013997:Time Factors
D002254:Carbonates; D002395:Catecholamines; D011955:Receptors, Drug; D004295:Dihydroxyphenylalanine; D008094:Lithium; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine